JPWO2020257248A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020257248A5
JPWO2020257248A5 JP2021574909A JP2021574909A JPWO2020257248A5 JP WO2020257248 A5 JPWO2020257248 A5 JP WO2020257248A5 JP 2021574909 A JP2021574909 A JP 2021574909A JP 2021574909 A JP2021574909 A JP 2021574909A JP WO2020257248 A5 JPWO2020257248 A5 JP WO2020257248A5
Authority
JP
Japan
Prior art keywords
prevotella
mammal
model
human
use according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021574909A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022537178A (ja
JP2022537178A5 (https=
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/038084 external-priority patent/WO2020257248A1/en
Publication of JP2022537178A publication Critical patent/JP2022537178A/ja
Publication of JPWO2020257248A5 publication Critical patent/JPWO2020257248A5/ja
Publication of JP2022537178A5 publication Critical patent/JP2022537178A5/ja
Pending legal-status Critical Current

Links

JP2021574909A 2019-06-17 2020-06-17 プレボテラ調製物ならびに慢性閉塞性肺疾患(copd)および他の肺状態の治療 Pending JP2022537178A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962862186P 2019-06-17 2019-06-17
US62/862,186 2019-06-17
PCT/US2020/038084 WO2020257248A1 (en) 2019-06-17 2020-06-17 Prevotella preparations and treating chronic obstructive pulmonary disease (copd) and other lung conditions

Publications (3)

Publication Number Publication Date
JP2022537178A JP2022537178A (ja) 2022-08-24
JPWO2020257248A5 true JPWO2020257248A5 (https=) 2023-05-09
JP2022537178A5 JP2022537178A5 (https=) 2023-05-09

Family

ID=74037580

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021574909A Pending JP2022537178A (ja) 2019-06-17 2020-06-17 プレボテラ調製物ならびに慢性閉塞性肺疾患(copd)および他の肺状態の治療

Country Status (11)

Country Link
US (1) US20220296657A1 (https=)
EP (1) EP3983067A4 (https=)
JP (1) JP2022537178A (https=)
KR (1) KR20220024466A (https=)
CN (1) CN114340732A (https=)
AU (1) AU2020295393A1 (https=)
BR (1) BR112021025416A2 (https=)
CA (1) CA3143597A1 (https=)
CO (1) CO2022000029A2 (https=)
MX (1) MX2021015711A (https=)
WO (1) WO2020257248A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020109620A2 (en) * 2018-11-30 2020-06-04 Ospedale San Raffaele S.R.L. Bacterial strains for medical uses
WO2022182707A1 (en) * 2021-02-26 2022-09-01 Evelo Biosciences, Inc. Compositions and methods for reducing cytokine expression
WO2022187064A1 (en) * 2021-03-01 2022-09-09 Evelo Biosciences, Inc. Compositions and methods of treating inflammation using prevotella histicola
WO2023146843A1 (en) * 2022-01-25 2023-08-03 Evelo Biosciences, Inc. Extracellular vesicle compositions and methods of use
WO2023200837A1 (en) * 2022-04-13 2023-10-19 Evelo Biosciences, Inc. Compositions and methods of treating inflammation using prevotella histicola
WO2024097250A1 (en) * 2022-10-31 2024-05-10 The Trustees Of Columbia University In The City Of New York Polymeric carrier for probiotics

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5965787A (en) 1995-08-31 1999-10-12 Mayo Foundation For Medical Education And Research HLA-DRBI peptides with specific binding affinity for HLA-DQ molecules: prevention and treatment of rheumatoid arthritis
US20040219142A1 (en) * 2002-07-19 2004-11-04 Abbott Laboratories S.A. Treatment of skin and nail disorders using TNFalpha inhibitors
AU2004298384A1 (en) * 2003-12-17 2005-06-30 N.V. Nutricia Lactic acid producing bacteria and lung function
MX2009010187A (es) 2007-03-27 2009-10-19 Procter & Gamble Metodos y estuches para administracion de probioticos.
WO2011053653A2 (en) 2009-10-30 2011-05-05 Mayo Foundation For Medical Education And Research Prevotella histicola preparations and the treatment of autoimmune conditions
JP2014196260A (ja) * 2013-03-29 2014-10-16 公立大学法人奈良県立医科大学 慢性閉塞性肺疾患の予防又は治療用組成物
EP3679798B1 (en) * 2015-02-03 2021-11-17 Mayo Foundation for Medical Education and Research Methods and materials for assessing and treating arthritis
CN108473963A (zh) * 2015-09-09 2018-08-31 雷维维科公司 用于异种移植的多重转基因猪
CN110352237B (zh) * 2017-02-28 2023-01-10 精密生物集团有限公司 可以有益地调节针对呼吸道病毒感染的免疫应答的长双歧杆菌
WO2019004668A1 (ko) * 2017-06-30 2019-01-03 주식회사 엠디헬스케어 프로테우스 속 세균 유래 나노소포 및 이의 용도
MX2020002660A (es) * 2017-09-08 2020-07-22 Evelo Biosciences Inc Vesiculas extracelulares de prevotella.
WO2020109620A2 (en) * 2018-11-30 2020-06-04 Ospedale San Raffaele S.R.L. Bacterial strains for medical uses

Similar Documents

Publication Publication Date Title
EP0583356B1 (en) A method for treating infectious respiratory diseases
CN114786659A (zh) 用于治疗汉坦病毒感染的mek抑制剂
JP2013126989A5 (https=)
JP2010138198A (ja) 医薬活性剤を含有する速溶解性口腔消耗性フィルム
BRPI0906851A2 (pt) uso de um sal do ácido acetilsalicílico para tratamento de infecções virais.
JP5970465B2 (ja) ペプチドおよびウイルス・ノイラミニダーゼ阻害剤を含んでなる組成物
JPWO2020257248A5 (https=)
WO2021211745A1 (en) Pirfenidone for coronavirus treatment
AU2013360691A1 (en) Ciclesonide for the treatment of airway disease in horses
JP2019531308A5 (https=)
BR9915946A (pt) Preparações contendo partìculas similares a vìrus como imunopotenciadores administrados através da mucosa
JP2019516797A (ja) 鼻詰まりを治療/予防するためのカルボン酸
WO2021216584A1 (en) Use of surfactant protein d to treat viral infections
CN101432002B (zh) 治疗慢性阻塞性肺疾病的方法和组合物
JP2023520929A (ja) コロナウイルス感染症の処置のための方法
Bergmann et al. Lung mechanics in orally immunized mice after aerolized exposure to influenza virus
JP7335954B2 (ja) 白頭翁サポニンb4の抗急性痛風性関節炎の医薬における用途
JPWO2021209739A5 (https=)
JP2023091085A (ja) 粘膜アジュバント
USRE38071E1 (en) Method for treating infectious respiratory diseases
JP2023548863A (ja) テトラヒドロカンナビノールおよびそれを含む組成物を用いて急性呼吸不全および/または急性呼吸窮迫症候群を治療するための組成物および方法
TW202122109A (zh) 經黏膜投予藥劑
CN108524550B (zh) Seb类毒素疫苗气溶胶肺递送免疫小鼠模型的制备方法
CN106822158B (zh) 红景天苷用于防治阻塞性睡眠呼吸暂停诱导型高血压
RU2249465C1 (ru) Способ лечения и профилактики иммунодефицитных состояний и заболеваний, связанных с бактериальной или вирусной агрессией